Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin
Authors:
- Annette C. MoserAMAnnette C. Moser
- Sara B.G. BasiagaSBSara B.G. Basiaga
- John E. SchielJSJohn E. Schiel
- David S. HageDHDavid S. Hage
- 1 April 2009
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1216 (16) , 3492-3500
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 GM044931)
- National Institutes of Health (RR015468-01)
This publication has 45 references indexed in Scilit:
- Characterization of the interaction between human serum albumin and morinBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Stability of warfarin solutions for drug–protein binding measurements: Spectroscopic and chromatographic studiesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005
- Drug‐human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detectionElectrophoresis, 2004
- Binding of Anti‐HIV Drugs to Human Serum AlbuminIUBMB Life, 2004
- Characterizing a Drug’s Primary Binding Site on AlbuminJournal of Pharmaceutical Sciences, 2003
- Five recombinant fragments of human serum albumin—tools for the characterization of the warfarin binding siteProtein Science, 2000
- Measurement of protein binding by ultracentrifugation.Chemical and Pharmaceutical Bulletin, 1985
- Changes in the circular dichroic spectrum of colchicine associated with its binding to tubulinBiochemistry, 1981
- An in vitro study of drug displacement interactions: warfarin-salicylate and warfarin-phenylbutazoneJournal of Pharmacy and Pharmacology, 1979